Comprehensive Financial Consultants Institutional, Inc. Astrazeneca PLC Transaction History
Comprehensive Financial Consultants Institutional, Inc.
- $231 Million
- Q1 2024
A detailed history of Comprehensive Financial Consultants Institutional, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Comprehensive Financial Consultants Institutional, Inc. holds 16,457 shares of AZN stock, worth $1.27 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
16,457
Previous 15,695
4.86%
Holding current value
$1.27 Million
Previous $1.06 Million
5.39%
% of portfolio
0.48%
Previous 0.5%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,248Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.74 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.8 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.32 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.67 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.34 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...